Atea Pharmaceuticals Inc. (AVIR)
NASDAQ · Healthcare
Atea Pharmaceuticals Inc. Revenue 2020–2021
Atea Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2020 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Atea Pharmaceuticals Inc. revenue for the quarter ending September 30, 2021 was 32.8 M.
- Atea Pharmaceuticals Inc. annual revenue for 2021 was 351.4 M, a 622.49% increase from 2020.
- Atea Pharmaceuticals Inc. annual revenue for 2020 was 48.6 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Atea Pharmaceuticals Inc. Revenue — FAQ
Atea Pharmaceuticals Inc. (AVIR) revenue over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Atea Pharmaceuticals Inc.'s revenue?
Atea Pharmaceuticals Inc. (AVIR) reported revenue of $351M for fiscal 2021.
Where can I see AVIR's revenue history?
The chart and table above show Atea Pharmaceuticals Inc.'s revenue by year and by quarter, including the growth rate.